A. Benjamin Suttle

Vascular endothelial growth factor inhibition is not an effective therapeutic strategy for relapsed or refractory multiple myeloma: a phase 2 study of pazopanib (GW786034).

G. Tricot, D. Demarini, A. Roberts, 2009, Blood.

Vascular endothelial growth factor inhibition is not an effective therapeutic strategy for relapsed or refractory multiple myeloma: a phase 2 study of pazopanib (GW786034).

G. Tricot, D. Demarini, A. Roberts, 2009, Blood.